High circulating levels of adiponectin have been strongly linked to improved BC risk and outcome[23,36,76], and adiponectin treatment was found to attenuate both cancer cell proliferation and mammary tumor progression in xenograft analysis of aggressive BC cells in mice[77]. This evidence concerns the gene ADIPOQ and breast cancer.